Featured Articles

Leica Biosystems declared the release of a remarkable update to the highly regarded BOND-III IHC and ISH stainer. The latest advance to the BOND-III stainer incorporates a unique set…
Read More...

Orthofix International declared the U.S. Food and Drug Administration (FDA) and European CE Mark approvals for its next-generation PhysioStim bone growth stimulators. The PhysiStim…
Read More...

Premier Biotech was awarded a 510 (k) clearance for the following drugs Amphetamine, Cocaine, Marijuana, Methamphetamine, Opiates and Phencyclidine from the Food and Drug Administration…
Read More...

Zydus Cadila which is a leading innovation-driven, global healthcare provider asserted that it has entered into a definitive agreement with Medicure International which is subsidiary of…
Read More...

MyBiotics Pharma which is a microbiome therapeutics company announced that it has entered into second option agreement with Ferring Holding Ltd. for the validation of MyBiotics'…
Read More...

Global pharmaceutical company, Glenmark affirmed poster presentations of data from clinical studies of Ryaltris which is an investigational fixed-dose combination nasal spray for…
Read More...

Biogen and Abbvie asserted voluntary worldwide withdrawal of ZINBRYTA for relapsing multiple sclerosis. Taking into account the limited number of patients who are being treated,…
Read More...

Ionis Pharmaceuticals which is a leader in antisense therapeutics asserted that the positive top-line data from a completed Phase 1/2 study of IONIS-HTTRx      in people with early…
Read More...

Ageless Forever asserts to offer GAINSWave which is an innovative noninvasive medical therapy that utilizes low-intensity shockwave therapy to treat Erectile Dysfunction symptoms. It…
Read More...

Regeneron Pharmaceuticals and Sanofi claimed that the U.S Food and Drug Administration has considered to assess the supplemental Biologics License Application (sBLA) of DUPIXENT as an…
Read More...

Jazz Pharmaceuticals affirmed that the U.S Food and Drug Administration has conceded for filing with standard review the company's New Drug Application requesting marketing approval for…
Read More...

Concert Pharmaceuticals asserted the next development candidate CTP-692, a novel drug for adjunctive treatment of schizophrenia, a devastating, chronic illness with significant unmet…
Read More...

Apnea Sciences Corporation asserted the availability of SnoreRx at selected CVS pharmacies. FDA has sanctioned SnoreRx to be denoted as the first and only oral appliance for treatment…
Read More...

Second Genome which is considered a leader in the development of novel medicines derived from the human microbiome initiated four collaborations with key academic institutions to assess…
Read More...

Spruce Biosciences which is a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders asserted the launch of its Congenital Adrenal Hyperplasia…
Read More...

OrthoSpin which is a portfolio company of the Trendlines Group declared that it had successfully completed a first-in-human case for smart, robotic external fixation system assuring…
Read More...

Celltex Therapeutics Corporation asserted its authorization to conduct an investigational protocol which is a Phase II B Wellness Protocol Clinical Study on Rheumatoid Arthritis and…
Read More...

Aridis Pharmaceuticals applying proprietary technologies to curate novel anti-infectives and immunotherapies for infectious diseases proclaimed that it has created a Joint Venture with …
Read More...

Beacon Discovery asserted the formulation of a multi-year drug discovery collaboration with Takeda Pharmaceutical Company aiming to develop G-protein coupled receptors paving way for…
Read More...

Longeveron asserted that its revolutionary Clinical Trial initiated to treat infants with Hypoplastic Left Heart Syndrome as the first patient received the treatment using the company's…
Read More...